We are delighted to present the new CFO of Reponex Thomas Kaas Selsø who will join the company on the 1st of March 2022.
We are delighted to present the new CFO of Reponex Thomas Kaas Selsø who will join the company on the 1st of March 2022.
Reponex Pharmaceuticals A/S
Slotsmarken 18, 2.th.
DK-2970 Hørsholm
Denmark
CVR 30082346
For general enquiries contact us at info@reponex.dk
For any drug quality issues, complaints or adverse events,
contact us at quality@reponex.dk